CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation.

ABSTRACT:

SUBMITTER: Xu Q 

PROVIDER: S-EPMC8850813 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature